These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6922228)

  • 21. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nursing of SLE patients. A discussion. Possible misunderstanding between the patient and nursing personnel].
    Yoshida K; Yamashita T; Otsuki S; Fujitake M
    Kurinikaru Sutadi; 1985 Nov; 6(11):1323-8. PubMed ID: 3853707
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacologic management of systemic lupus erythematosus: nursing implications.
    Malseed RT; Wilson BA
    Medsurg Nurs; 1993 Oct; 2(5):422-4. PubMed ID: 8220648
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic lupus erythematosus. Part 2: Diagnosis, treatment modalities, and nursing management.
    Lash AA
    Medsurg Nurs; 1993 Oct; 2(5):375-85. PubMed ID: 8220640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer therapeutic approaches for systemic lupus erythematosus.
    Ginzler EM; Dvorkina O
    Rheum Dis Clin North Am; 2005 May; 31(2):315-28. PubMed ID: 15922148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of autoimmune haemolytic anaemia and immune thrombocytopenia (Evans' syndrome) in systemic lupus erythematosus.
    Pasangna J; Lim CB; Duraisamy G; Lajin I
    Malays J Pathol; 1994 Jun; 16(1):79-82. PubMed ID: 16329581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Undesirable side effect of glucocorticoids in the treatment of systemic lupus erythematosus].
    Prikryl P; Kunovská VL
    Vnitr Lek; 1977 Mar; 23(3):260-4. PubMed ID: 855220
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nursing of a patient with systemic lupus erythematosus - nursing keypoints and management].
    Takagi S; Kawai Y; Shimono Y; Ito K
    Kango Gijutsu; 1979 Sep; 25(12):77-84. PubMed ID: 259120
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spontaneous infrapatellar tendon rupture in a patient with systemic lupus erythematosus].
    Jakobsen LP; Knudsen TB; Bloch T
    Ugeskr Laeger; 2000 Sep; 162(38):5088-9. PubMed ID: 11014141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Mease PJ; Ginzler EM; Gluck OS; Schiff M; Goldman A; Greenwald M; Cohen S; Egan R; Quarles BJ; Schwartz KE
    J Rheumatol; 2005 Apr; 32(4):616-21. PubMed ID: 15801015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nursing plans for SLE patients].
    Yoshida K
    Kurinikaru Sutadi; 1985 Nov; 6(11):1311-5. PubMed ID: 3853705
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nursing of a patient with SLE and psychiatric symptoms].
    Takagi S; Kikuta K; Ueda A; Shina T
    Kango Gijutsu; 1978 Sep; 24(12):42-52. PubMed ID: 251649
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
    Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
    J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.
    Van Vollenhoven RF; McGuire JL
    Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus.
    Sarkissian T; Beyene J; Feldman B; McCrindle B; Silverman ED
    Arthritis Rheum; 2007 Feb; 56(2):631-8. PubMed ID: 17265498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T; Beyenne J; Feldman B; Adeli K; Silverman E
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
    Mok CC; To CH; Ma KM
    Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx.
    Gonzàlez N; Xicoy B; Olivé A; Jové J; Ribera JM; Feliu E
    Ear Nose Throat J; 2009 Aug; 88(8):E4-5. PubMed ID: 19688705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.